Implementing the Memorandum of Understanding signed between the Egyptian Drug Authority and the South African Health Products Regulatory Authority (SAHPRA).

Egypt, as represented by the Egyptian Drug Authority (EDA), and South Africa, as represented by the South African Health Products Regulatory Authority (SAHPRA), are extending an invitation to industry partners to participate in the pilot phase of the Work Sharing Initiative (WSI) aimed at streamlining the registration process for biological products in both countries through joint assessment. As stakeholders in the pharmaceutical and biotechnology sectors, your collaboration is paramount to the success of this initiative.

By participating in this joint assessment initiative, industry partners will have the opportunity to:

Collaborate with the leading African regulatory authorities to shape the future of regulatory policies and practices.

Contribute to the development of regulatory frameworks that support mutual reliance and access to medicines and vaccines.

We invite you to express your interest in participating in this transformative initiative by submitting a formal application in the enclosed form after reviewing the concept paper of the initiative and its operating procedures.

Deadline to receive your application is [28th February 2025] via email:

EDA: Bioreg.rec@edaegypt.gov.eg

SAHPRA: eoi@sahpra.org.za